These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9645371

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones.
    Wucherpfennig KW, Sette A, Southwood S, Oseroff C, Matsui M, Strominger JL, Hafler DA.
    J Exp Med; 1994 Jan 01; 179(1):279-90. PubMed ID: 7505801
    [Abstract] [Full Text] [Related]

  • 4. A review of T-cell receptors in multiple sclerosis: clonal expansion and persistence of human T-cells specific for an immunodominant myelin basic protein peptide.
    Wucherpfennig KW, Hafler DA.
    Ann N Y Acad Sci; 1995 Jul 07; 756():241-58. PubMed ID: 7544075
    [Abstract] [Full Text] [Related]

  • 5. Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes.
    Wucherpfennig KW, Catz I, Hausmann S, Strominger JL, Steinman L, Warren KG.
    J Clin Invest; 1997 Sep 01; 100(5):1114-22. PubMed ID: 9276728
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW, Hafler DA, Strominger JL.
    Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8896-900. PubMed ID: 7568039
    [Abstract] [Full Text] [Related]

  • 8. Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: implications for the initiation of the autoimmune response in multiple sclerosis.
    Zhang X, Tang Y, Sujkowska D, Wang J, Ramgolam V, Sospedra M, Adams J, Martin R, Pinilla C, Markovic-Plese S.
    Eur J Immunol; 2008 May 12; 38(5):1297-309. PubMed ID: 18412170
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.
    Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA, Yang D, Rivera VM, Killian JK, Zhang JZ.
    J Immunol; 1999 Sep 15; 163(6):3530-8. PubMed ID: 10477628
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
    Bourdette DN, Chou YK, Whitham RH, Buckner J, Kwon HJ, Nepom GT, Buenafe A, Cooper SA, Allegretta M, Hashim GA, Offner H, Vandenbark AA.
    J Immunol; 1998 Jul 15; 161(2):1034-44. PubMed ID: 9670985
    [Abstract] [Full Text] [Related]

  • 15. MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cells.
    Chou YK, Weinberg AD, Buenafe A, Bourdette DN, Whitham R, Kaleeba JA, Robey IF, Kavanagh DG, Offner H, Vandenbark AA.
    J Neurosci Res; 1996 Sep 15; 45(6):838-51. PubMed ID: 8892096
    [Abstract] [Full Text] [Related]

  • 16. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes.
    Hong J, Zang YCQ, Li S, Rivera VM, Zhang JZ.
    Eur J Immunol; 2004 Mar 15; 34(3):870-881. PubMed ID: 14991617
    [Abstract] [Full Text] [Related]

  • 17. Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99.
    Ausubel LJ, Krieger JI, Hafler DA.
    J Immunol; 1997 Sep 01; 159(5):2502-12. PubMed ID: 9278344
    [Abstract] [Full Text] [Related]

  • 18. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M, Ochi H, Matsushita S, Irie A, Nishimura Y, Kira J.
    Tissue Antigens; 2001 May 01; 57(5):447-56. PubMed ID: 11556969
    [Abstract] [Full Text] [Related]

  • 19. Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis.
    Fridkis-Hareli M, Santambrogio L, Stern JN, Fugger L, Brosnan C, Strominger JL.
    J Clin Invest; 2002 Jun 01; 109(12):1635-43. PubMed ID: 12070311
    [Abstract] [Full Text] [Related]

  • 20. Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein.
    Chou YK, Henderikx P, Vainiene M, Whitham R, Bourdette D, Chou CH, Hashim G, Offner H, Vandenbark AA.
    J Neurosci Res; 1991 Feb 01; 28(2):280-90. PubMed ID: 1709690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.